A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2002
11/21/2002	US20020172663 Localized myocardial injection method for treating ischemic myocardium
11/21/2002	DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia
11/21/2002	CA2451116A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447015A1 Insulin producing cells derived from human embryonic stem cells
11/21/2002	CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002	CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002	CA2446589A1 Methods for treating cancer
11/21/2002	CA2446113A1 Methods for inactivating viruses
11/21/2002	CA2446108A1 Compositions for use in treating ige-associated disorders
11/21/2002	CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002	EP1257657A2 Autoregulatory expression vector for gene therapy
11/20/2002	EP1257653A2 Phosphodiesterase type 7b
11/20/2002	EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses
11/20/2002	EP1257639A2 Nucleozymes with endonuclease activity
11/20/2002	EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
11/20/2002	EP1257632A1 Simultaneous stimulation and concentration of cells
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257290A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries
11/20/2002	EP1257289A1 Immunotherapy using interleukin 13 receptor subunit alpha 2
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP1162987B1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
11/20/2002	EP1011697A4 Targeted system for removing tumor cells from cell populations
11/20/2002	EP0954326A4 A process for viral inactivation of lyophilized blood proteins
11/20/2002	EP0871458B1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
11/20/2002	EP0758394B1 Bifunctional protein, preparation and use
11/20/2002	CN1380902A Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
11/20/2002	CN1380813A Primary composition containing lipophilic bioactive compound
11/20/2002	CN1380095A Ointment for curing rheumatism and osteoarthropathy
11/20/2002	CN1380090A Kidney-supplementing gestation-promoting capsule
11/20/2002	CN1380089A Anti-cancer medicine and its preparation method
11/20/2002	CN1380084A Medicine for external application for curing diseases of digestive tract, repercussion and stopping pain and its preparation method
11/20/2002	CN1380082A Chinese medicine for curing female chronic inflammation
11/20/2002	CN1380077A Programming cell lethal revellent
11/20/2002	CN1380068A Medicine for curing enterogastric diseases and its preparation method
11/20/2002	CN1380067A Medicine with functions of reducing sugar and reducing blood-fat and its preparation method
11/20/2002	CN1380066A Fattening injection preparation for pork type pig
11/20/2002	CN1094373C Medicine for curing pernio and its preparing method
11/20/2002	CN1094371C Compound medicine for curing leukemia
11/20/2002	CN1094368C Chinese medicine for curing alopecia
11/20/2002	CN1094367C External-use medicine for curing skin disease, venereal disease and gynaopathy
11/20/2002	CN1094366C Ointment for curing burn and scald and its preparing process
11/20/2002	CN1094364C Human placenta-pollen health-care food and its preparing method
11/20/2002	CN1094362C Traditional Chinese medicinal pill with function of benefiting kidney and primordial energy
11/20/2002	CN1094361C Composition comprising propolis and essential oil
11/20/2002	CN1094360C Fumigation roll for treating scald
11/20/2002	CN1094358C Hypoglycemic medicine composition
11/20/2002	CN1094357C Anticancer oral liquid
11/19/2002	US6482806 Product of heat treatment of uronic acid, food, drink, or drug including the product
11/19/2002	US6482617 Viable contaminant particle free adenoviruses, their preparation and use
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002	US6482443 Antler herb medicine fermented with chicken gizzard and a method for preparation thereof
11/19/2002	US6482442 Substance mixture for topical application comprising olive oil and honey
11/19/2002	US6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same
11/19/2002	US6482406 Cell-based gene therapy for the pulmonary system
11/19/2002	US6482405 Antitumor
11/19/2002	US6482404 Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
11/19/2002	US6482328 Method and apparatus for magnetically separating selected particles, particularly biological cells
11/19/2002	US6482231 Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002	CA2227312C Nutraceutical antler powder and a method of producing same
11/19/2002	CA2154432C Cosmetic and/or dermatologic composition containing thermal or mineral water and an anti-acne and anti-aging active ingredient
11/19/2002	CA2100866C Spray method for delivering direct feed microorganisms to poultry
11/19/2002	CA2092821C Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organs
11/19/2002	CA2086101C Immune suppressive product from milk
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090559A1 A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090551A2 Self-containing lactococcus strain
11/14/2002	WO2002090526A2 Human secreted proteins
11/14/2002	WO2002089846A1 Topical medication for burns and wounds
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089746A2 Hematopoietic stem cell chimerism to treat autoimmune disease
11/14/2002	WO2002089737A2 Separation of platelets from whole blood for use as a healant
11/14/2002	WO2002089730A2 Compounds and methods for the modulation of cd154
11/14/2002	WO2002089726A2 Method of making a homogeneous preparation of hematopoietic stem cells
11/14/2002	WO2002089711A1 Submucosal xenografts
11/14/2002	WO2002089675A2 Wound closure system and methods
11/14/2002	WO2002089658A2 Microvascular free flaps for local or systemic delivery
11/14/2002	WO2002078439A3 Prevascularized constructs for implantation to provide blood perfusion
11/14/2002	WO2002074948A3 Animal tissue with carbohydrate antigens compatible for human transplantation
11/14/2002	WO2002062392A3 Water-soluble compositions of bioactive lipophilic compounds
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	WO2002060376A3 Induction of tolerance by apoptotic and/or necrotic cells
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	WO2001087317A1 Adsorbent for endocrine disruptors and foods and drinks containing the same
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	US20020169214 Methods and compositions for inactivating viruses
11/14/2002	US20020169132 Polypeptides

1 ... 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 ... 1259